Richard Thomas Williams is CHIEF MEDICAL OFFICER at Kinnate Biopharma Inc. (KNTE). They have made 1 open-market trade across 1 company since 2022, most recently 2024-03-01.
CIK 0001825148
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $678K since 2022, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| KNTE | 67,588 | $179K |
Shares reported on the most recent Form 4, priced at the 2024-03-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KNTE | BUY | 2022-03-11 | 2022-03-15 | $8.47 | $678K | +25.8% | +11.8% | +0.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.